Insider · CIK 0002023255
Peter McNamara
Files at TECX (AVROBIO, Inc.). First filing Mar 5, 2026, latest Oct 2, 2026.
In brief
Peter McNamara files SEC Form 4 as officer at TECX (AVROBIO, Inc.). Since Mar 5, 2026, Peter McNamara has reported 0 open-market buys worth $0 and 6 open-market sells worth $288k, the latest filed on Oct 2, 2026.
A track record needs three past buys with six months of prices behind them; Peter McNamara has 0, so none is measured yet.
The newest scored trade: sold $12k of TECX on Sep 30, 2026, filed Oct 2, 2026, scored 0 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 6 sells worth $288k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TECX: AVROBIO, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | AVROBIO, Inc. | $12k 536 shares | -1% | +56% from low-39% from high | |
| 0Weak | AVROBIO, Inc. | $1,570 43 shares | -0% | +156% from low-1% from high | |
| 0Weak | AVROBIO, Inc. | $1,505 43 shares | -0% | +150% from low-3% from high | |
| 0Weak | AVROBIO, Inc. | $6,020 172 shares | -0% | +134% from low-4% from high | |
| 5Weak | AVROBIO, Inc. | $189k 6,262 shares | -10% | +145% from low0% from high | |
| 12Weak | AVROBIO, Inc. | $78k 3,299 shares | -8% | +66% from low-8% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 30, 2026 | TECX TECTONIC THERAPEUTIC, INC. | 493 0.00% of outstanding | $12k | Sep 30, 2026 | $3,075 |
| Aug 12, 2026 | TECX TECTONIC THERAPEUTIC INC | 129 0.00% of outstanding | $4,111 | Aug 12, 2026 | $6,020 |
| Jun 30, 2026 | TECX TECTONIC THERAPEUTIC, INC. | 172 0.00% of outstanding | $5,691 | Jun 30, 2026 | none |
| Mar 6, 2026 | TECX TECTONIC THERAPEUTIC, INC. | 6,262 0.03% of outstanding | $174k | Mar 6, 2026 | $78k |
| Mar 4, 2026 | TECX TECTONIC THERAPEUTIC INC | 1,650 0.01% of outstanding | $40k | Mar 4, 2026 | $36k |
| Mar 3, 2026 | TECX TECTONIC THERAPEUTIC INC | 1,649 0.01% of outstanding | $38k | Mar 3, 2026 | none |
Transactions
Every row this insider has filed, 29 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | TECX AVROBIO, Inc. | FTax withholding Common Stock10b5-1 | -444 | $23.67 | $11k | 54,841 | 12 d ago |
| Sep 30, 2026 | TECX AVROBIO, Inc. | SOpen-market sale Common Stock10b5-1 | -536 | $23.04 | $12k | 54,305 | 12 d ago |
| Sep 3, 2026 | TECX AVROBIO, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +21,000 | $0.00 | $0 | 21,000 | 36 d ago |
| Aug 25, 2026 | TECX AVROBIO, Inc. | MOption exercise Common Stock10b5-1 | +43 | $14.71 | $633 | 55,328 | Aug 26, 2026 |
| Aug 25, 2026 | TECX AVROBIO, Inc. | SOpen-market sale Common Stock10b5-1 | -43 | $36.52 | $1,570 | 55,285 | Aug 26, 2026 |
| Aug 25, 2026 | TECX AVROBIO, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -43 | $0.00 | $0 | 7,787 | Aug 26, 2026 |
| Aug 12, 2026 | TECX AVROBIO, Inc. | MOption exercise Common Stock10b5-1 | +43 | $14.71 | $633 | 55,328 | Aug 14, 2026 |
| Aug 12, 2026 | TECX AVROBIO, Inc. | SOpen-market sale Common Stock10b5-1 | -43 | $35.00 | $1,505 | 55,285 | Aug 14, 2026 |
| Aug 12, 2026 | TECX AVROBIO, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -43 | $0.00 | $0 | 7,830 | Aug 14, 2026 |
| Jun 30, 2026 | TECX AVROBIO, Inc. | MOption exercise Common Stock10b5-1 | +172 | $14.71 | $2,530 | 55,457 | Jul 1, 2026 |
| Jun 30, 2026 | TECX AVROBIO, Inc. | SOpen-market sale Common Stock10b5-1 | -172 | $35.00 | $6,020 | 55,285 | Jul 1, 2026 |
| Jun 30, 2026 | TECX AVROBIO, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -172 | $0.00 | $0 | 7,873 | Jul 1, 2026 |
| Mar 6, 2026 | TECX AVROBIO, Inc. | MOption exercise Common Stock10b5-1 | +2,500 | $2.38 | $5,950 | 61,332 | Mar 9, 2026 |
| Mar 6, 2026 | TECX AVROBIO, Inc. | MOption exercise Common Stock10b5-1 | +215 | $14.71 | $3,163 | 61,547 | Mar 9, 2026 |
| Mar 6, 2026 | TECX AVROBIO, Inc. | SOpen-market sale Common Stock10b5-1 | -6,047 | $30.00 | $181k | 55,500 | Mar 9, 2026 |
| Mar 6, 2026 | TECX AVROBIO, Inc. | SOpen-market sale Common Stock10b5-1 | -215 | $35.00 | $7,525 | 55,285 | Mar 9, 2026 |
| Mar 6, 2026 | TECX AVROBIO, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -2,500 | - | - | 31,959 | Mar 9, 2026 |
| Mar 6, 2026 | TECX AVROBIO, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -215 | $0.00 | $0 | 8,045 | Mar 9, 2026 |
| Mar 3, 2026 | TECX AVROBIO, Inc. | SOpen-market sale Common Stock10b5-1 | -1,649 | $22.06 | $36k | 37,482 | Mar 5, 2026 |
| Mar 4, 2026 | TECX AVROBIO, Inc. | AGrant or award Common Stock10b5-1 | +23,000 | $0.00 | $0 | 60,482 | Mar 5, 2026 |
| Mar 4, 2026 | TECX AVROBIO, Inc. | SOpen-market sale Common Stock10b5-1 | -1,650 | $25.00 | $41k | 58,832 | Mar 5, 2026 |
| Mar 4, 2026 | TECX AVROBIO, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative10b5-1 | +21,000 | $0.00 | $0 | 21,000 | Mar 5, 2026 |
| Feb 4, 2026 | TECX AVROBIO, Inc. | FTax withholding Common Stock | -1,748 | $23.22 | $41k | 39,131 | Feb 10, 2026 |
| Dec 22, 2025 | TECX AVROBIO, Inc. | MOption exercise Common Stock | +7,000 | $2.98 | $21k | 40,879 | Dec 29, 2025 |
| Dec 22, 2025 | TECX AVROBIO, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -7,000 | - | - | 25,065 | Dec 29, 2025 |
| Sep 25, 2025 | TECX AVROBIO, Inc. | AGrant or award Common Stock | +4,550 | $0.00 | $0 | 33,879 | Sep 29, 2025 |
| Sep 25, 2025 | TECX AVROBIO, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +8,260 | $0.00 | $0 | 8,260 | Sep 29, 2025 |
| Dec 3, 2024 | TECX AVROBIO, Inc. | MOption exercise Common Stock | +3,500 | $2.38 | $8,330 | 14,188 | Dec 5, 2024 |
| Dec 3, 2024 | TECX AVROBIO, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -3,500 | - | - | 34,459 | Dec 5, 2024 |
Questions about Peter McNamara
Answered from the filings on this page, as of the latest one.
Is Peter McNamara buying or selling?
In the last 12 months Peter McNamara reported 0 open-market buys worth $0 and 6 open-market sells worth $288k on SEC Form 4; the latest was sold $12k of TECX on Sep 30, 2026. Grants, option exercises and tax withholding are not counted.
How did Peter McNamara's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter McNamara has 0.
Where does Peter McNamara file Form 4?
Peter McNamara has filed Form 4 at TECX (AVROBIO, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.